🇪🇺 Lynparza in European Union

EMA authorised Lynparza on 23 October 2014

Marketing authorisation

EMA — authorised 23 October 2014

  • Status: approved

Lynparza in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Lynparza approved in European Union?

Yes. EMA authorised it on 23 October 2014.

Who is the marketing authorisation holder for Lynparza in European Union?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.